Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM5 | P08912 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 6/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | MAPT | P10636 | 5/20 | 0.45 |
| ▸ | HPGD | P15428 | 4/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.45 |
| ▸ | MEN1 | O00255 | 4/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.45 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | CCR6 | P51684 | 3/20 | 0.45 |
| ▸ | HKDC1 | Q2TB90 | 3/20 | 0.45 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | STAT3 | P40763 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29906366 | 1.00 | CHRM5 (0.46) | CHRM5LMNAALDH1A1MAPTHPGD | |
| SCHEMBL29906407 | 0.89 | HIF1A (0.50) | CHRM5LMNAALDH1A1MAPTHPGD | |
| SCHEMBL26982495 | 0.89 | HIF1A (0.50) | CHRM5LMNAALDH1A1MAPTHPGD | |
| SCHEMBL12833645 | 0.85 | TBXAS1 (0.54) | CHRM5LMNAALDH1A1MAPTHPGD | |
| SCHEMBL29906418 | 0.82 | CHRM5 (0.49) | CHRM5LMNAALDH1A1MAPTHPGD | |
| SCHEMBL26982468 | 0.82 | CHRM5 (0.49) | CHRM5LMNAALDH1A1MAPTHPGD | |
| SCHEMBL26982491 | 0.82 | CHRM5 (0.46) | CHRM5LMNAALDH1A1MAPTHPGD | |
| SCHEMBL29906359 | 0.82 | CHRM5 (0.46) | CHRM5LMNAALDH1A1MAPTHPGD | |
| SCHEMBL29906421 | 0.79 | PTPN1 (0.48) | CHRM5ALDH1A1MAPTNPSR1HTT | |
| SCHEMBL26982481 | 0.79 | PTPN1 (0.48) | CHRM5ALDH1A1MAPTNPSR1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240174589-A1 | PHOTOREDOX RADICAL BENZYLATION PROCESS | CENTRE NAT RECH SCIENT (FR) | 2024-05-30 | — | — | US | disclosed |
| EP-4301722-A1 | PHOTOREDOX RADICAL BENZYLATION PROCESS | Centre National de la Recherche Scientifique (FR) | 2024-01-10 | — | — | EP | disclosed |
| EP-4053096-A1 | PHOTOREDOX RADICAL BENZYLATION PROCESS | Centre national de la recherche scientifique (FR) | 2022-09-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240174589-A1 | PHOTOREDOX RADICAL BENZYLATION PROCESS | H1-2, H1-3, H1-0 | CHRM5 2553/4885LMNA 3404/4885ALDH1A1 860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.